Excella Partners with BEAM Diagnostics To Combat Substance Misuse
Saved in:
| Title: | Excella Partners with BEAM Diagnostics To Combat Substance Misuse |
|---|---|
| Authors: | Excella |
| Source: | Business Wire (English). 08/13/2019. |
| Abstract: | Excella announced that it has been selected as the primary technology partner of BEAM Diagnostics, Inc. to develop its medical mobile app for taking patient vitals. The purpose of the app, called Beacon, is to help medical professionals prospectively detect alcohol misuse and risk of relapse. Through the combination of behavioral economics and advanced technology, Beacon helps determine if a patient is suffering from alcohol use disorder (AUD) more efficiently than traditional methods. [ABSTRACT FROM PUBLISHER] |
| Database: | Regional Business News |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Excella announced that it has been selected as the primary technology partner of BEAM Diagnostics, Inc. to develop its medical mobile app for taking patient vitals. The purpose of the app, called Beacon, is to help medical professionals prospectively detect alcohol misuse and risk of relapse. Through the combination of behavioral economics and advanced technology, Beacon helps determine if a patient is suffering from alcohol use disorder (AUD) more efficiently than traditional methods. [ABSTRACT FROM PUBLISHER] |
|---|
